Floatz logo

Bendamustine

Hematopoietic and Lymphoid System Neoplasm

Yale UniversitySmall moleculePhase 2Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Hematopoietic and Lymphoid System Neoplasm cohort.

Asset / SponsorPhaseRating
Methylene Blue
Mayo Clinic
Phase 3BB
ag-120
M.D. Anderson Cancer Center
Phase 1/2CCC
Synthetic Mva-Based Sars-Cov-2 Vaccine Geo-Cm04S1
GeoVax, Inc.
Phase 2CCC
Ipilimumab
OHSU Knight Cancer Institute
Phase 1CC
Ponatinib
OHSU Knight Cancer Institute
Phase 1CC

View all 33 →

Same molecule, other indications

Bendamustine is also rated in:

mantle cell lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
73 / 100
View asset →
diffuse large B-cell lymphomaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →